Characteristics of children with non-Hodgkin lymphoma associated with primary immune deficiency diseases: Descriptions of five patients

Pediatric Hematology and Oncology

Volumn 30, Issue 6, 2013, Pages 544-553

  Emir, Suna ^a   Vezir, Emine ^a   Azkur, Dilek ^a   Demir, Haci Ahmet ^a   Metin, Ayşe ^a  

^a Ankara Children's Hematology Oncology Education and Research Hospital   (Turkey)

Author keywords

Ataxia telangiectasia; Non Hodgkin's lymphoma; Pediatric oncology; T cell immunodeficiencies

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE; ANTINEOPLASTIC AGENT; MONOCLONAL ANTIBODY; R-CHOP PROTOCOL;

ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; B CELL LYMPHOMA; BLOOM SYNDROME; CHILD; CLINICAL ARTICLE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMMUNE DEFICIENCY; MALE; NONHODGKIN LYMPHOMA; PRIMARY IMMUNE DEFICIENCY; RELAPSE; REMISSION; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; T CELL LYMPHOMA; TREATMENT OUTCOME; WISKOTT ALDRICH SYNDROME; ADOLESCENT; ADULT; CASE REPORT; COMPLICATION; FEMALE; INFANT; LYMPHOMA, NON-HODGKIN; NEWBORN; PATHOLOGY; WISKOTT-ALDRICH SYNDROME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ATAXIA TELANGIECTASIA; BLOOM SYNDROME; CHILD; COMMON VARIABLE IMMUNODEFICIENCY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LYMPHOMA, NON-HODGKIN; MALE; PREDNISONE; RETROSPECTIVE STUDIES; RISK FACTORS; VINCRISTINE; WISKOTT-ALDRICH SYNDROME;

EID: 84881536669     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2013.792893     Document Type: Article

References (19)

1. Rosen FS, Cooper MD, Wedgwood RJ. The primary immunodeficiencies. N Engl J Med. 1995;333:431-440.
2. Chinen J, Anmuth D, Franklin AR, Shearer WT. Long-term follow-up of patients with primary immunodeficiencies. J Allergy Clin Immunol. 2007;120:795-797. (Pubitemid 47531854)
3. Tran H, Nourse J, Hall S, et al. Immunodeficiency-associated lymphomas. Blood Rev. 2008;22:261-281.
4. Sandoval C, Swift M. Treatment of lymphoidmalignancies in patientswith ataxia telangiectasia. Med Pediatr Oncol. 1998;31:491-497. (Pubitemid 28535916)
5. Seidemann K, Tiemann M, Henze G, et al. Therapy for Non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM Trials. Med Pediatr Oncol. 1999;33:536-544.
6. Murphy SB. Classification staging and results of treatment of childhood non-Hodgkin's lymphomas: dissimilarities from lymphomas in adults. Semin Oncol. 1980;7:329-332.
7. Turvey SE, Bonilla FA, Junker AK. Primary immunodeficiency diseases: a practical guide for clinicians. Postgrad Med J. 2009;85:660-666.
8. Varan A, Buyukpamukçu M, Ersoy F, et al. Malignant solid tumors associated with congenital immunodeficiency disorders. Pediatr Hematol Oncol. 2004;21:441-451. (Pubitemid 38886674)
9. Bautista-QuachMA, Bedros A,Wang J. Subsequent development of diffuse large B-cell lymphomas and Hodgkin lymphoma associated with primary immune disorder in a 6-year-old female: a case report and review of the literature. J Pediatr Hematol Oncol. 2011;33:e320-e325.
10. Janic D, Dokmanovic L, Jovanovic N, Lazic J. T-cell acute lymphoblastic leukemia in a child with ataxia-telangiectasia: case report. J Pediatr Hematol Oncol. 2007;29:713-715. (Pubitemid 47549185)
11. Sharma LM, Kashyap R, Gupta S, Bhargava M. B-cell acute lymphoblastic leukemia in a child with ataxia telangiectasia. Pediatr Hematol Oncol. 2008 Jun;25(5):473-476. (Pubitemid 351874102)
12. Yanofsky RA, Seshia SS, Dawson AJ, et al. Ataxia-telangiectasia: atypical presentation and toxicity of cancer treatment. Can J Neurol Sci. 2009;36:462-464.
13. Vandenberghe E, Van Hove J, Brock P, et al. Non-endemic Burkitt's lymphoma in a patient with Bloom's syndrome. Leuk Lymphoma. 1993;10:377-382. (Pubitemid 23256617)
14. Shcherbina A, Miki H, Kenney DM, et al. WASP and N-WASP in human platelets differ in sensitivity to protease calpain. Blood. 2001,98:2988-2991.
15. Du S, ScuderiR,MalickiDM,et al.Hodgkin's and non-Hodgkin'slymphomas occurring in two brothers withWiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol. 2011;14:64-70.
16. Pasic S, Vujic D, Djuricic S, et al. Burkitt lymphoma-induced ileocolic intussusception in Wiskott- Aldrich syndrome. J Pediatr Hematol Oncol. 2006;28:48-50.
17. Shabbat S, Aharoni J, Sarid L, et al. Rituximab as monotherapy and in addition to reduced CHOP in children with primary immunodeficiency and Non-Hodgkin lymphoma. Pediatr Blood Cancer. 2009;52:664-666.
18. Coccia P, Mastrangelo S, Ruggiero A, et al. Treatment of Pharyngeal Non-Hodgkin lymphoma in a patient withWiskott-Aldrich syndrome. Pediatr Blood Cancer. 2012;59:318-319.
19. Cunningham-Rundles C, Siegal FP, Cunningham-Rundles S, Lieberman P. Incidence of cancer in 98 patients with common varied immunodeficiency. J Clin Immunol. 1987;7:294-299. (Pubitemid 17146797)